Evidence map›Paper›PMID 40634285›Full record

ArticleNature communications2025

Inhibiting heme piracy by pathogenic Escherichia coli using de novo-designed proteins.

Daniel R Fox, Kazem Asadollahi, Imogen Samuels, Bradley A Spicer, Ashleigh Kropp, Christopher J Lupton, Kevin Lim, Chunxiao Wang, Hari Venugopal, Marija Dramicanin and 2 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Molecules (Basel, Switzerland) · 2026
    Review
  2. Article
  3. First inhibitor of a bacterial two-partner secretion system.bioRxiv : the preprint server for biology · 2026
    Article
  4. Protein engineering: status report.Protein engineering, design & selection : PEDS · 2026
    Review
  5. Article
  6. Review
  7. Exceptional Heme Tolerance inLife (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Daniel R FoxDepartment of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, Australia.ORCID http://orcid.org/0000-0003-0271-2776
Kazem AsadollahiDepartment of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria, 3010, Australia.
Imogen SamuelsDepartment of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria, 3010, Australia.
Bradley A SpicerDepartment of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, 3800, Australia.ORCID http://orcid.org/0000-0002-9595-918X
Ashleigh KroppDepartment of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, Australia.
Christopher J LuptonDepartment of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, 3800, Australia.ORCID http://orcid.org/0000-0002-4617-4853
Kevin LimThe Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, 3052, Australia.
Chunxiao WangDepartment of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria, 3010, Australia.
Hari VenugopalRamaciotti Centre for Cryo-Electron Microscopy, Biomedicine Discovery Institute, Monash University, Clayton, 3800, Australia.ORCID http://orcid.org/0000-0001-5230-2973
Marija DramicaninThe Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, 3052, Australia.
Gavin J KnottDepartment of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, 3800, Australia. gavin.knott@monash.edu.ORCID http://orcid.org/0000-0002-9007-6273
Rhys GrinterDepartment of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, Australia. rhys.grinter@unimelb.edu.au.ORCID http://orcid.org/0000-0002-8195-5348

Funding

Department of Education and Training | Australian Research Council (ARC) DP230102150Department of Health | National Health and Medical Research Council (NHMRC) APP1197376
6 · The paper itself

Abstract

Iron is an essential nutrient for most bacteria and is often growth-limiting during infection, due to the host sequestering free iron as part of the innate immune response. To obtain the iron required for growth, many bacterial pathogens encode transporters capable of extracting the iron-containing cofactor heme directly from host proteins. Pathogenic E. coli and Shigella spp. produce the outer membrane transporter ChuA, which binds host hemoglobin and extracts its heme cofactor, before importing heme into the cell. Heme extraction by ChuA is a dynamic process, with the transporter capable of rapidly extracting heme from hemoglobin in the absence of an external energy source, without forming a stable ChuA-hemoglobin complex. In this work, we utilise a combination of structural modelling, Cryo-EM, X-ray crystallography, mutagenesis, and phenotypic analysis to understand the mechanistic detail of this process. Based on this understanding we utilise artificial intelligence-based protein design to create binders capable of inhibiting E. coli growth by blocking hemoglobin binding to ChuA. By screening a limited number of these designs, we identify several binders that inhibit E. coli growth at low nanomolar concentrations, without experimental optimisation. We determine the structure of a subset of these binders, alone and in complex with ChuA, demonstrating that they closely match the computational design. This work demonstrates the utility of de novo-designed proteins for inhibiting bacterial nutrient uptake and uses a workflow that could be applied to integral membrane proteins in other organisms.

Indexed as

Escherichia coliEscherichia coli ProteinsHemeBacterial Outer Membrane ProteinsCryoelectron MicroscopyCrystallography, X-RayHemoglobinsIronModels, MolecularProtein BindingBacterial Outer Membrane ProteinsEscherichia coli ProteinsHemeHemoglobinsIron

Identifiers

PMID40634285
PMCPMC12241658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.